SAM
RDHL

Smartleaf Asset Management’s Redhill Biopharma RDHL Stock Holding History

Smartleaf Asset Management’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4 Hold
5
– – ﹤0.01% 3454
2026
Q1 		$4 Hold
5
– – ﹤0.01% 3497
2025
Q4 		$5 Buy
+5
New +$7 ﹤0.01% 3481

Other funds holding RDHL

YAG
Yorkville Advisors Global Mountainside, New Jersey $86.2M AUM 41.28% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Smartleaf Asset Management's RDHL Position: Q2 2026 in Review

Smartleaf Asset Management held its Redhill Biopharma (RDHL) position steady in Q2 2026 at 5 shares worth $4. The position accounts for ﹤0.01% of the portfolio, ranked #3454.

Smartleaf Asset Management first reported a position in RDHL in Q4 2025 and has held it in 3 quarters since. The position peaked at $5 in Q4 2025. 14 funds tracked by Wall St. Rank hold RDHL as of Q2 2026.

  • Smartleaf Asset Management held 5 shares of Redhill Biopharma worth $4 as of Q2 2026.
  • Smartleaf Asset Management left its Redhill Biopharma share count unchanged in Q2 2026.
  • Redhill Biopharma made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #3454 holding.
  • Smartleaf Asset Management first reported a position in Redhill Biopharma in Q4 2025 and has held it in 3 quarters since.
  • Smartleaf Asset Management's Redhill Biopharma position peaked at $5 in Q4 2025.
  • 14 funds tracked by Wall St. Rank held Redhill Biopharma as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.